Completed enrollment in LEGEND’s pivotal cohort with 125 patients in high-risk, BCG-unresponsive NMIBC with carcinoma in situ Reported preliminary 6-month...
Year
Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear...
NANO Nuclear Energy Inc. NANO Nuclear Energy Inc. NANO Nuclear Reports Fiscal Year 2025 Financial Results and Provides Business Update...
If you purchase an independently reviewed product or service through a link on our website, WWD may receive an affiliate...
- Dosing is underway in the Phase 3 CYB003 PARADIGM program which comprises two 12-week randomized, double-blind, placebo-controlled studies (APPROACH™...
Torrid Holdings Inc., the plus-size fashion retailer known for catering to women sizes 10 through 30, is closing multiple retail...
